STOUT JAY S (Chief Technology Officer) sold 3.8% of their position (10.13K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $251.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 4/10/2026ACC: 0001702969-26-000006
Officer· Chief Technology Officer
Since Apr 2023
-10.13K
Net shares
Net seller
$251.6K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
10.13K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−8.61K
Price / share
$24.83
Trade value
$213.89K
% of position
3.3%
4/8/2026
264.57K→255.96K
Common Stock
Direct
Shares
−1.52K
Price / share
$24.83
Trade value
$37.69K
% of position
0.6%
4/8/2026
255.96K→254.44K
Total
Net shares
−10.13K
Net value
-$251.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/8/2026 | S · Sale | −8.61K | $24.83 | $213.89K | 3.3% | 264.57K | 255.96K |
| Common Stock Direct | 4/8/2026 | S · Sale | −1.52K | $24.83 | $37.69K | 0.6% | 255.96K | 254.44K |
| Total | −10.13K | -$251.58K | ||||||
Derivative Transactions0
No derivative transactions reported